Showing 1361-1370 of 4003 results for "".
Ethics and Dermatology: Finding Harmony in Daily Practice
https://practicaldermatology.com/topics/general-topics/PD0109_06-php/22893/While there are no easy resolutions to ethical dilemmas, experts emphasize the importance of reflection and discussion in building higher ethical standards.Emerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
https://practicaldermatology.com/programs/cme/emerging-and-practice-changing-data-in-immunotherapy-strategies-for-melanoma/36330/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage IIB/IIC Melanoma
https://practicaldermatology.com/programs/cme/efficacy-and-safety-outcomes-for-adjuvant-immunotherapy-driving-guideline-recommendations-for-stage-iibiic-melanoma/36324/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Isotretinoin Online: Avoid Risk and Assure Safe Access
https://practicaldermatology.com/topics/practice-management/isotretinoin-online-avoid-risk-and-assure-safe-access/21441/Patients are buying the drug online without a prescription. Here's what dermatologists need to know to help protect patients and themselves.Clinical Data Prompting Guideline Updates for Subcutaneous ICIs in Melanoma
https://practicaldermatology.com/programs/cme/clinical-data-prompting-guideline-updates-for-subcutaneous-icis-in-melanoma/36329/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Clinical Implications of Neoadjuvant Therapy Guideline Updates in Resectable Melanoma
https://practicaldermatology.com/programs/cme/clinical-implications-of-neoadjuvant-therapy-guideline-updates-in-resectable-melanoma/36323/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.The Importance of Diversity in Clinical Trials
https://practicaldermatology.com/issues/april-2025/the-importance-of-diversity-in-clinical-trials/35606/The disproportionate representation of certain segments of the population in clinical trials is no secret, and research has shown that psoriasis studies are the least racially diverse of all dermatology studies in the US.Ask Me Anything: Mona Sadeghpour, MD
https://practicaldermatology.com/youngmd-connect/wrap-ups/ask-me-anything-mona-sadeghpour-md/24215/An intimate YoungMD Connect virtual mentorship event encourages exchange of ideas, advice, and feedback.Welcome 2024: Trends to Watch in Cosmetic Surgery
https://practicaldermatology.com/topics/practice-management/welcome-2024-trends-to-watch-in-cosmetic-surgery/24030/Look for noninvasive treatments, advancements in technology, and shifting age demographics.Physician Spotlight: Stefan Weiss, MD
https://practicaldermatology.com/programs/practical-dermatology/physician-spotlight-stefan-weiss-md/24017/From enhancing the diagnosis and treatment of skin diseases to identifying unmet clinical needs, artificial intelligence (AI) and big data are upending the practice of dermatology.